Literature DB >> 18535805

CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis.

Maciej Pech1, Gero Wieners, Rafal Kryza, Oliver Dudeck, Max Seidensticker, Konrad Mohnike, Ulf Redlich, Ricarda Rühl, Peter Wust, Günther Gademann, Jens Ricke.   

Abstract

PURPOSE: To compare local tumor control after percutaneous tumor ablation by interstitial laser therapy (ILT) or CT-guided brachytherapy (CTGB). PATIENTS AND METHODS: In a matched pair analysis including 18 patients with 36 liver metastases of colorectal primary, both ILT and CTGB were performed in different lesions. The following matching factors were considered: (i) tumor size < or = 5 cm, and (ii) execution of chemotherapy after tumor ablation. Primary endpoint was local tumor control.
RESULTS: Treated lesions were identical in terms of tumor size and all matching criteria were fulfilled in all patients except for the performance of adjuvant chemotherapy. Median follow-up was 14 months (3-24 months) for both groups. Only five of 18 patients (28%) demonstrated local tumor progression after CTGB, whereas in ten of 18 patients (56%) tumor progression was found after ILT. Differences encountered were significant for all patients (p = 0.04), whereas in those who fulfilled all matching criteria (n = 14) the level of statistical significance was not reached (p = 0.23).
CONCLUSION: CTGB demonstrated superior local tumor control compared to ILT in long-term follow-up.

Entities:  

Mesh:

Year:  2008        PMID: 18535805     DOI: 10.1007/s00066-008-1815-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  8 in total

Review 1.  [Interventional procedures for hepatic metastases].

Authors:  T Helmberger
Journal:  Chirurg       Date:  2010-06       Impact factor: 0.955

2.  [Update on interstitial brachytherapy].

Authors:  T Bretschneider; N Peters; P Hass; J Ricke
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

3.  Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.

Authors:  Shinji Sugahara; Hidetsugu Nakayama; Kuniaki Fukuda; Masashi Mizumoto; Mari Tokita; Masato Abei; Junichi Shoda; Yasushi Matsuzaki; Eriko Thono; Koji Tsuboi; Koichi Tokuuye
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

4.  Effect of irradiation on gene expression of rat liver adhesion molecules: in vivo and in vitro studies.

Authors:  Federico Moriconi; Ihtzaz Malik; Ghayyor Ahmad; Joszef Dudas; Margret Rave-Fränk; Hilke Vorwerk; Andrea Hille; Clemens Friedrich Hess; Giuliano Ramadori; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

5.  Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study.

Authors:  Nikolaos Tselis; Georgios Chatzikonstantinou; Christos Kolotas; Natasa Milickovic; Dimos Baltas; Nikolaos Zamboglou
Journal:  Eur Radiol       Date:  2013-03-21       Impact factor: 5.315

6.  Retracted article: In vitro derivation of mammalian germ cells from stem cells and their potential therapeutic application.

Authors:  Shigeo Saito; Ying-Chu Lin; Yoshinobu Murayama; Yukio Nakamura; Richard Eckner; Heiner Niemann; Kazunari K Yokoyama
Journal:  Cell Mol Life Sci       Date:  2015-10-06       Impact factor: 9.261

7.  Accuracy assessment of a potential clinical use of navigation-guided intra-operative liver metastasis brachytherapy-a planning study.

Authors:  E Herrmann; D Terribilini; P Manser; M K Fix; G Toporek; D Candinas; S Weber; D M Aebersold; K Loessl
Journal:  Strahlenther Onkol       Date:  2018-07-18       Impact factor: 3.621

Review 8.  Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization).

Authors:  Peter Hass; Konrad Mohnike
Journal:  Viszeralmedizin       Date:  2014-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.